Metabolic syndrome and Weakness

Summary:

Weakness is found among people with Metabolic syndrome, especially for people who are female, 60+ old.

The study analyzes which people have Weakness with Metabolic syndrome. It is created by eHealthMe based on reports of 25 people who have Metabolic syndrome from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Metabolic syndrome?

Metabolic syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease) is found to be associated with 286 drugs and 373 conditions by eHealthMe. Check the latest studies of Metabolic syndrome.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 09, 2026

25 people who have Metabolic Syndrome and Weakness are studied.

Would you have Weakness when you have Metabolic syndrome?

Gender of people who have Metabolic Syndrome and experienced Weakness *:

female: 91.3 %
male: 8.7 %

Age of people who have Metabolic Syndrome and experienced Weakness *:

Common co-existing conditions for these people *:

High Blood Pressure: 5 people, 20.00%
Weight Loss: 3 people, 12.00%
Glucose Tolerance Impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis): 3 people, 12.00%
Upper Respiratory Tract Infection: 2 people, 8.00%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 4.00%
Low Density Lipoprotein Increased (cholesterol increased in blood): 1 person, 4.00%
Hepatitis C: 1 person, 4.00%
Hepatic Neoplasm Malignant (liver cancer): 1 person, 4.00%
Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 1 person, 4.00%
Essential Hypertension (primary hypertension): 1 person, 4.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Nausea (feeling of having an urge to vomit): 12 people, 48.00%
Dizziness: 9 people, 36.00%
Muscle Aches (muscle pain): 5 people, 20.00%
Anaemia (lack of blood): 5 people, 20.00%
Headache (pain in head): 5 people, 20.00%
Stress And Anxiety: 5 people, 20.00%
Fatigue (feeling of tiredness): 5 people, 20.00%
Insulin Resistance: 4 people, 16.00%
Weight Loss: 4 people, 16.00%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 4 people, 16.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Weakness?

- Check whether Weakness is associated with a drug or a condition

Related publications that referenced our studies

Salama N, Eid A, Swedan A, Hatem A, "Increased prevalence of premature ejaculation in men with metabolic syndrome", The Aging Male, 2017 Feb .
Salama N, Eid A, Swedan A, Hatem A, "Increased prevalence of premature ejaculation in men with metabolic syndrome", The Aging Male, 2017 Feb .

Related studies:

Treatments, associated drugs and conditions:

Metabolic syndrome (2,653 reports)
Weakness (586,876 reports)

All the drugs that are associated with Weakness:

Weakness (3,639 drugs)

All the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Weakness and Metabolic syndrome, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.